Docusign Inc. (NASDAQ:DOCU – Get Free Report) Director Anna Marrs sold 363 shares of Docusign stock in a transaction on Friday, December 5th. The stock was sold at an average price of $64.50, for a total transaction of $23,413.50. Following the sale, the director directly owned 11,525 shares in the company, valued at $743,362.50. This trade represents a 3.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Anna Marrs also recently made the following trade(s):
- On Tuesday, December 2nd, Anna Marrs sold 365 shares of Docusign stock. The stock was sold at an average price of $68.54, for a total transaction of $25,017.10.
- On Monday, September 15th, Anna Marrs sold 728 shares of Docusign stock. The stock was sold at an average price of $80.30, for a total value of $58,458.40.
Docusign Price Performance
Shares of DOCU traded down $5.43 during trading hours on Friday, reaching $65.67. 8,925,162 shares of the company’s stock traded hands, compared to its average volume of 2,738,978. The business’s fifty day simple moving average is $69.80 and its two-hundred day simple moving average is $75.45. The firm has a market capitalization of $13.21 billion, a price-to-earnings ratio of 49.38, a P/E/G ratio of 3.51 and a beta of 0.98. Docusign Inc. has a twelve month low of $63.41 and a twelve month high of $107.86.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on DOCU. Wedbush decreased their target price on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a research note on Friday. Royal Bank Of Canada reiterated a “sector perform” rating and set a $95.00 price target on shares of Docusign in a report on Friday. Robert W. Baird cut their price target on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday. Wall Street Zen upgraded shares of Docusign from a “hold” rating to a “buy” rating in a report on Saturday, September 13th. Finally, Evercore ISI cut their price objective on Docusign from $92.00 to $80.00 and set an “in-line” rating on the stock in a research note on Friday. Four equities research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $86.71.
Get Our Latest Analysis on DOCU
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. IFP Advisors Inc raised its holdings in Docusign by 31.9% during the 3rd quarter. IFP Advisors Inc now owns 1,955 shares of the company’s stock worth $145,000 after purchasing an additional 473 shares during the last quarter. Strategic Advocates LLC bought a new position in Docusign during the third quarter worth about $50,000. CIBC Bancorp USA Inc. acquired a new position in shares of Docusign during the 3rd quarter worth about $522,000. Centaurus Financial Inc. increased its stake in shares of Docusign by 3.4% in the 3rd quarter. Centaurus Financial Inc. now owns 5,582 shares of the company’s stock valued at $402,000 after acquiring an additional 184 shares during the last quarter. Finally, Coldstream Capital Management Inc. increased its stake in shares of Docusign by 21.1% in the 3rd quarter. Coldstream Capital Management Inc. now owns 4,147 shares of the company’s stock valued at $299,000 after acquiring an additional 723 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Docusign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than Docusign
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
